A phase II study investigating the safety and efficacy of neoadjuvant atezolizumab in muscle invasive bladder cancer (ABACUS).

被引：30
|
作者：
Powles, Thomas
Rodriguez-Vida, Alejo
Duran, Ignacio
Crabb, Simon J.
Van der Heijden, Michiel Simon
Pous, Albert Font
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.4506
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4506
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of disitamab vedotin combined with gemcitabine as neoadjuvant therapy for muscle-invasive bladder cancer: A multi-center, single-arm, phase II trial
    Yang, C.
    Huang, H.
    Zeng, X.
    Dai, H.
    Zhou, G.
    Wang, S.
    Hu, Z.
    ANNALS OF ONCOLOGY, 2024, 35 : S1148 - S1148
  • [22] Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder
    Szabados, Bernadett
    Kockx, Mark
    Assaf, Zoe June
    van Dam, Pieter-Jan
    Rodriguez-Vida, Alejo
    Duran, Ignacio
    Crabb, Simon J.
    Van Der Heijden, Michiel S.
    Pous, Albert Font
    Gravis, Gwenaelle
    Herranz, Urbano Anido
    Protheroe, Andrew
    Ravaud, Alain
    Maillet, Denis
    Mendez, Maria Jose
    Suarez, Cristina
    Linch, Mark
    Prendergast, Aaron
    Tyson, Charlotte
    Stanoeva, Diana
    Daelemans, Sofie
    Rombouts, Miche
    Mariathasan, Sanjeev
    Tea, Joy S.
    Mousa, Kelly
    Sharma, Shruti
    Aleshin, Alexey
    Banchereau, Romain
    Castellano, Daniel
    Powles, Thomas
    EUROPEAN UROLOGY, 2022, 82 (02) : 212 - 222
  • [23] Final results of neoadjuvant atezolizumab in cisplatin-ineligible patients with muscle-invasive urothelial cancer of the bladder
    Yuxuan Song
    Tao Xu
    World Journal of Urology, 2023, 41 : 1697 - 1698
  • [24] Neoadjuvant Phase II Studies of Modified Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Muscle-Invasive Bladder Cancer
    Adesunloye, Bamidele A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (36) : 4170 - U405
  • [25] Efficacy and safety of dose-dense gemcitabine plus cisplatin as neoadjuvant chemotherapy for muscle-invasive bladder cancer
    Hattori, Yuto
    Fujiwara, Tasuku
    Hagimoto, Hiroki
    Kokubun, Hidetoshi
    Murata, Shiori
    Makita, Noriyuki
    Abe, Yohei
    Kubota, Masashi
    Tohi, Yoichiro
    Tsutsumi, Naofumi
    Shibasaki, Noboru
    Inoue, Koji
    Kawakita, Mutsushi
    Yamasaki, Toshinari
    INTERNATIONAL JOURNAL OF UROLOGY, 2024, 31 (10) : 1102 - 1106
  • [26] Neoadjuvant Chemoradiotherapy Followed by Radical Cystectomy for Muscle-Invasive Bladder Cancer: Analysis of Efficacy and Safety in 119 Patients
    Fujiwara, Motohiro
    Tanaka, Hajime
    Kobayashi, Masaki
    Nakamura, Yuki
    Fan, Bo
    Ishikawa, Yudai
    Fukuda, Shohei
    Toda, Kazuma
    Yoshida, Soichiro
    Yokoyama, Minato
    Yoshimura, Ryoichi
    Fujii, Yasuhisa
    CLINICAL GENITOURINARY CANCER, 2024, 22 (02) : 193 - 200.e1
  • [27] Final results of neoadjuvant atezolizumab in cisplatin-ineligible patients with muscle-invasive urothelial cancer of the bladder
    Song, Yuxuan
    Xu, Tao
    WORLD JOURNAL OF UROLOGY, 2023, 41 (06) : 1697 - 1698
  • [28] Phase II study of concurrent chemoradiotherapy (CCRth) for bladder preservation in the treatment of muscle invasive bladder cancer
    El Taher, A. Mohamed
    Mekawy, M.
    Eid, S. Shehata
    Mostafa, H. G. El Din
    Aziz, A. M. Abdel
    Kamel, Y. Mostafa
    EJC SUPPLEMENTS, 2007, 5 (04): : 310 - 310
  • [29] Feasibility and efficacy of gemcitabine and carboplatin neoadjuvant chemotherapy in muscle-invasive bladder cancer
    Koie, T.
    Yamamoto, H.
    Okamoto, A.
    Hatakeyama, S.
    Momose, A.
    Iwabuchi, I.
    Yoneyama, T.
    Hashimoto, Y.
    Kamimura, N.
    Ohyama, C.
    Saijo, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [30] A phase Ⅱ study of neoadjuvant chemotherapy followed by organ preservation in patients with muscle-invasive bladder cancer
    Chinna Babu Dracham
    Narendra Kumar
    Santosh Kumar
    Arun Elangovan
    Budhi Singh Yadav
    Ravimohan SMavuduru
    Anupam Lal
    Pramod KGupta
    Rakesh Kapoor
    Asian Journal of Urology, 2022, (03) : 318 - 328
12345